THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

Galderma Q3 Sales Climb; Confirms FY26 Core EBITDA Margin View, Lifts Sales Growth Outlook; Stock Up

SW, GALDY), a Swiss pharmaceutical company, reported Thursday strong growth in third-quarter sales.

Read the full account of the story

More from the Markets desk

More from Markets · Back to Polaris Insights